Research Projects

Our Research

We are proud to work with top scientists with a shared aim of reducing morbidity, increasing survival rates, addressing health inequalities, and improving quality of life for men with prostate cancer.

We fund a diverse portfolio of projects at leading institutions in prostate cancer, ranging from early-stage biological insights to drug development.

About Us

Showing 7 Active Projects

Tackling therapeutic resistance in prostate cancer disparities

Reducing prostate cancer disparities by inhibiting cell signalling and growth.

$50,000 Starts: March 2023

Baylor College of Medicine

Discovering genetic drivers of prostate cancer in Black men

Identifying race specific variants, pathways, and genes that drive prostate cancer risk in Black men compared to White men.

$49,999 Starts: March 2023

Baylor College of Medicine

Linking the immune system to prostate cancer disparities

Establishing the role of the immune system in racial disparities in prostate cancer.

$100,000 Starts: March 2023

Clark Atlanta University

Reducing Barriers to Screening in Black Men with Prostate Cancer

Examining the links between neighborhood factors, barriers to Prostate Specific Antigen screening access, and prostate cancer mortality.

$400,000 Starts: October 2022

Dana-Farber Cancer Institute at Harvard University

Clipping prostate cancer's wings

Targeting sugars to block prostate cancer spread

$200,000 per year Starts: August 2021

Newcastle University, Stanford University, and University of South Carolina

Improving Radiotherapy

Combining radiotherapy with other drugs to improve patient outcomes

$140,000/year Starts: January 2020

University of Oxford

STAMPEDE: which drug will work best for me?

Developing a test to choose treatment for individual patients

$190,000/year Starts: December 2020

UCL